Literature DB >> 4470894

The syndrome of familial dwarfism and high plasma immunoreactive human growth hormone.

Z Laron.   

Abstract

In 1966 we described a syndrome of familial dwarfism which was indistinguishable both clinically and in many of the laboratory findings from pituitary dwarfism, but in which there were abnormally high plasma concentrations of immunoreactive human growth hormone (IR-HGH). The possibility was raised that in these cases the circulating growth hormone is biologically inactive. Additional patients were described two years later, and in recent years we have reported additional clinical and laboratory findings in these and newly-discovered patients, all of whom were of Jewish origin. Subsequently, this syndrome was detected in non-Jewish populations.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4470894

Source DB:  PubMed          Journal:  Birth Defects Orig Artic Ser        ISSN: 0547-6844


  3 in total

1.  Diverse growth hormone receptor gene mutations in Laron syndrome.

Authors:  M A Berg; J Argente; S Chernausek; R Gracia; J Guevara-Aguirre; M Hopp; L Pérez-Jurado; A Rosenbloom; S P Toledo; U Francke
Journal:  Am J Hum Genet       Date:  1993-05       Impact factor: 11.025

2.  Leprechaunism: an inherited defect in a high-affinity insulin receptor.

Authors:  L J Elsas; F Endo; E Strumlauf; J Elders; J H Priest
Journal:  Am J Hum Genet       Date:  1985-01       Impact factor: 11.025

3.  Height-reducing variants and selection for short stature in Sardinia.

Authors:  Magdalena Zoledziewska; Carlo Sidore; Charleston W K Chiang; Serena Sanna; Antonella Mulas; Maristella Steri; Fabio Busonero; Joseph H Marcus; Michele Marongiu; Andrea Maschio; Diego Ortega Del Vecchyo; Matteo Floris; Antonella Meloni; Alessandro Delitala; Maria Pina Concas; Federico Murgia; Ginevra Biino; Simona Vaccargiu; Ramaiah Nagaraja; Kirk E Lohmueller; Nicholas J Timpson; Nicole Soranzo; Ioanna Tachmazidou; George Dedoussis; Eleftheria Zeggini; Sergio Uzzau; Chris Jones; Robert Lyons; Andrea Angius; Gonçalo R Abecasis; John Novembre; David Schlessinger; Francesco Cucca
Journal:  Nat Genet       Date:  2015-09-14       Impact factor: 38.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.